1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FAM210A CTRPv2 pan-cancer AAC 0.15 8e-05
mRNA BEND4 CTRPv2 pan-cancer AAC -0.16 8e-05
mRNA LGALS9 CTRPv2 pan-cancer AAC 0.15 8e-05
mRNA EFNA2 CTRPv2 pan-cancer AAC 0.15 8e-05
mRNA CYP3A7 CTRPv2 pan-cancer AAC 0.14 8e-05
mRNA KRBOX4 CTRPv2 pan-cancer AAC -0.15 8e-05
mRNA TWIST2 CTRPv2 pan-cancer AAC -0.14 8e-05
mRNA CSF3R CTRPv2 pan-cancer AAC 0.14 8e-05
mRNA WNT5A CTRPv2 pan-cancer AAC -0.15 8e-05
mRNA TRIM51 CTRPv2 pan-cancer AAC 0.15 8e-05
Download CSV